Literature DB >> 30113297

Differences in the effects of mutations in GP131, a guinea pig cytomegalovirus homologue of pentameric complex component UL130, on macrophage and epithelial cell infection.

Takuya Miura1,2, Reina Makino1, Kouhei Yamada1,3, Miku Matsuura1,4, Misaki Okumura1, Souichi Yamada5, Shinji Watanabe1,6, Naoki Inoue1.   

Abstract

As congenital cytomegalovirus (CMV) infection is the major cause of developmental abnormalities in children, the development of effective vaccines is critical to public health. Recent studies have demonstrated that the pentameric complex (Pentamer) of glycoproteins, which is required for human CMV infection of endothelial and epithelial cells, could be a potent vaccine antigen. As guinea pig CMV (GPCMV) infects congenitally and encodes homologues of all Pentamer components, GPCMV models are considered to be useful for the development of vaccine strategies. Here, to clarify the precise requirement of GP131, one of the GPCMV Pentamer components, for the infection of epithelial cells and macrophages, we prepared several mutants with a charged amino acid-to-alanine alteration in GP131 and found some differences in the effects of the mutations on the infection of the two cell types, suggesting the existence of cell type-dependent recognition or function of Pentamer in GPCMV infection.

Entities:  

Keywords:  cell tropism; cytomegalovirus; entry; epithelial cells; guinea pig; macrophage

Mesh:

Substances:

Year:  2018        PMID: 30113297     DOI: 10.1099/jgv.0.001137

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  J Gen Virol       Date:  2020-02-18       Impact factor: 3.891

2.  Roles of GP33, a guinea pig cytomegalovirus-encoded G protein-coupled receptor homolog, in cellular signaling, viral growth and inflammation in vitro and in vivo.

Authors:  Miei Takeda; Shinji Watanabe; Harutaka Katano; Kazuma Noguchi; Yuko Sato; Sayaka Kojima; Takuya Miura; Ryuichi Majima; Souichi Yamada; Naoki Inoue
Journal:  PLoS Pathog       Date:  2018-12-20       Impact factor: 6.823

Review 3.  Pathogen at the Gates: Human Cytomegalovirus Entry and Cell Tropism.

Authors:  Christopher C Nguyen; Jeremy P Kamil
Journal:  Viruses       Date:  2018-12-11       Impact factor: 5.048

4.  Rat Cytomegalovirus Virion-Associated Proteins R131 and R129 Are Necessary for Infection of Macrophages and Dendritic Cells.

Authors:  Iris K A Jones; Nicole N Haese; Philippe Gatault; Zachary J Streblow; Takeshi F Andoh; Michael Denton; Cassilyn E Streblow; Kiley Bonin; Craig N Kreklywich; Jennifer M Burg; Susan L Orloff; Daniel N Streblow
Journal:  Pathogens       Date:  2020-11-19

5.  A Fully Protective Congenital CMV Vaccine Requires Neutralizing Antibodies to Viral Pentamer and gB Glycoprotein Complexes but a pp65 T-Cell Response Is Not Necessary.

Authors:  K Yeon Choi; Alistair McGregor
Journal:  Viruses       Date:  2021-07-27       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.